Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


Articles published in Arch Pathol Lab Med

Retrieve available abstracts of 25 articles:
HTML format



Single Articles


    September 2024
  1. QI Z, Ha T, Feng W, Karnoub M, et al
    Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies
    Arch Pathol Lab Med. 2024 Sep 20. doi: 10.5858/arpa.2024-0014.
    PubMed     Abstract available


    July 2024
  2. CECCHINI MJ
    Pathways to Precision: Guideline for Programmed Death Ligand-1 and Tumor Mutation Burden Testing to Support the Selection of Immune Checkpoint Therapies in Lung Cancer.
    Arch Pathol Lab Med. 2024;148:754-756.
    PubMed    


    May 2024
  3. HUNG YP, Chirieac LR
    Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.
    Arch Pathol Lab Med. 2024;148:e77-e89.
    PubMed     Abstract available


  4. BLAAUWGEERS H, Filipello F, Lissenberg-Witte B, Doglioni C, et al
    Loose Tumor Cells in Pulmonary Arteries of Lung Adenocarcinoma Resection Specimens: No Correlation With Survival, Despite High Prevalence.
    Arch Pathol Lab Med. 2024;148:588-594.
    PubMed     Abstract available


    April 2024
  5. SUN Q, Li W, Yang D, Lin PP, et al
    The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in Non-Small Cell Lung Cancer Patients.
    Arch Pathol Lab Med. 2024 Apr 18. doi: 10.5858/arpa.2023-0455.
    PubMed     Abstract available


  6. SHOLL LM, Awad M, Basu Roy U, Beasley MB, et al
    Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International As
    Arch Pathol Lab Med. 2024 Apr 16. doi: 10.5858/arpa.2023-0536.
    PubMed     Abstract available


  7. MILLER LJ, Holmes IM, Lew M
    An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers.
    Arch Pathol Lab Med. 2024;148:409-418.
    PubMed     Abstract available


    March 2024
  8. BLATNIK A, Dragos VS, Blatnik O, Stegel V, et al
    A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period.
    Arch Pathol Lab Med. 2024;148:299-309.
    PubMed     Abstract available


    December 2023
  9. NAMBIRAJAN A, Sood R, Khatoon W, Malik PS, et al
    Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Ch
    Arch Pathol Lab Med. 2023 Dec 6. doi: 10.5858/arpa.2023-0229.
    PubMed     Abstract available


  10. HOCKING AJ, Thomas EM, Prabhakaran S, Jolley A, et al
    Molecular Characterization of Testicular Mesothelioma and the Role of Asbestos as a Causative Factor.
    Arch Pathol Lab Med. 2023;147:1446-1450.
    PubMed     Abstract available


    August 2023
  11. LECHNER A, Rai A, Rojas-Rudilla V, Kuang Y, et al
    Atypical Droplet Digital Polymerase Chain Reaction Patterns That Indicate Uncommon but Clinically Actionable EGFR Mutations in Lung Cancer.
    Arch Pathol Lab Med. 2023 Aug 28. doi: 10.5858/arpa.2023-0088.
    PubMed     Abstract available


  12. LAMI K, Bychkov A, Matsumoto K, Attanoos R, et al
    Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping: A Clustering Approach to Establish a Ground Truth for Downstream Applications.
    Arch Pathol Lab Med. 2023;147:885-895.
    PubMed     Abstract available


    July 2023
  13. CHO WC, Vanderbeck K, Nagarajan P, Milton DR, et al
    SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
    Arch Pathol Lab Med. 2023;147:758-766.
    PubMed     Abstract available


    June 2023
  14. ELFVING H, Thurfjell V, Mattsson JSM, Backman M, et al
    Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies.
    Arch Pathol Lab Med. 2023 Jun 30. doi: 10.5858/arpa.2022-0327.
    PubMed     Abstract available


    March 2023
  15. BRCIC L, Le Stang N, Gallob F, Pissaloux D, et al
    A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.
    Arch Pathol Lab Med. 2023;147:313-322.
    PubMed     Abstract available


    February 2023
  16. NOVA-CAMACHO LM, Gomez-Dorronsoro M, Guarch R, Cordoba A, et al
    Cardiac Metastasis From Solid Cancers: A 35-Year Single-Center Autopsy Study.
    Arch Pathol Lab Med. 2023;147:177-184.
    PubMed     Abstract available


    January 2023
  17. KIM MY, Kim H, Sung JA, Koh J, et al
    Whole Mitochondrial Genome Analysis in Non-Small Cell Lung Carcinoma Reveals Unique Tumor-Specific Somatic Mutations.
    Arch Pathol Lab Med. 2023 Jan 5. doi: 10.5858/arpa.2022-0175.
    PubMed     Abstract available


    October 2022
  18. YAO Q, Bai Q, Zhang X, Ji G, et al
    Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing.
    Arch Pathol Lab Med. 2022;146:1234-1242.
    PubMed     Abstract available


    August 2022
  19. XU H, Fan F, Gong Y, Jing X, et al
    Diagnostic Challenges in Fine-Needle Aspiration Cytology of Mediastinal Tumors and Lesions.
    Arch Pathol Lab Med. 2022;146:960-974.
    PubMed     Abstract available


    June 2022
  20. MATA DA, Harries L, Williams EA, Hiemenz MC, et al
    Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer.
    Arch Pathol Lab Med. 2022 Jun 30. pii: 483419. doi: 10.5858/arpa.2021-0313.
    PubMed     Abstract available


    March 2022
  21. BAKER JA, Sireci AN, Marella N, Cannon HK, et al
    Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization.
    Arch Pathol Lab Med. 2022;146:351-359.
    PubMed     Abstract available


    November 2021
  22. BERNICKER EH, Xiao Y, Croix DA, Yang B, et al
    Understanding Factors Associated With Anaplastic Lymphoma Kinase Testing Delays in Patients With Non-Small Cell Lung Cancer in a Large Real-World Oncology Database.
    Arch Pathol Lab Med. 2021 Nov 9. pii: 473659. doi: 10.5858/arpa.2021-0029.
    PubMed     Abstract available


  23. WANG M, Gilani S, Xu H, Cai G, et al
    Salivary Gland-type Tumors of the Lung.
    Arch Pathol Lab Med. 2021;145:1379-1386.
    PubMed     Abstract available


  24. LAWRENCE L, Kunder CA, Fung E, Stehr H, et al
    Performance Characteristics of Mutational Signature Analysis in Targeted Panel Sequencing.
    Arch Pathol Lab Med. 2021;145:1424-1431.
    PubMed     Abstract available


    October 2021
  25. KEPPENS C, Van Royen Y, Brysse A, Cotteret S, et al
    Incidents in Molecular Pathology: Frequency and Causes During Routine Testing.
    Arch Pathol Lab Med. 2021;145:1270-1279.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.